Doxorubicin immunoconjugates containing bivalent, lysosomally-Cleavable dipeptide linkages
作者:Gene M Dubowchik、Shilpa Radia、Harold Mastalerz、Michael A Walker、Raymond A Firestone、H Dalton King、Sandra J Hofstead、David Willner、Shirley J Lasch、Pamela A Trail
DOI:10.1016/s0960-894x(02)00194-4
日期:2002.6
Bivalent doxorubicin (DOX)-dipeptides (16a-c) were prepared and conjugated to the monoclonal antibody BR96. The dipeptides are cleaved by lysosomal proteases following internalization of the resulting immunoconjugates. Conjugate 18b demonstrated antigen-specific in vitro tumor cell killing activity (IC50 = 0.2 muM) that was equipotent to DOX with a near doubling of drug molecules/MAb. Size exclusion chromatography showed 18b to be a noncovalent dimer that was formed immediately upon conjugation. (C) 2002 Elsevier Science Ltd. All rights reserved.